Our Blog – What moves us

Molnupiravir: The next cure for Cov-2?

Molnupiravir: The next cure for Cov-2?

Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug originally developed by Emory University for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral effect...

mehr lesen
Smart cars for ECJ

Smart cars for ECJ

The patent dispute between Nokia and Daimler concerning alleged infringement of various mobile communications patents will now step to the ECJ. On Thursday December 17, 2020 the Düsseldorf Regional Court (LG) announced submitting several questions to the ECJ...

mehr lesen
Union trademarks in the UK after Brexit

Union trademarks in the UK after Brexit

The Brexit becomes effective At the end of the year, the transitional period expires and the Brexit becomes effective. Recently, the rules for the extension of Union trademarks to the UK have been clarified: 1. All Union trademarks.. registered or to be registered by...

mehr lesen
mRNA Corona vaccines: A step towards normality

mRNA Corona vaccines: A step towards normality

The second Corona wave As the second Corona wave is accelerating in Europe and the US, thereby forcing us again to restrict our social interaction to a bare minimum, the announcements in recent days by Pfizer/BioNTech and Moderna of highly effective vaccines...

mehr lesen
Our chance to control the pandemic globally

Our chance to control the pandemic globally

Controlling COVID19 infections is essential to prevent further damage to society and the collapse of health care systems. PCR-based methods have been the gold standard testing approach for the first phase of this pandemic. However, low throughput, high costs and long...

mehr lesen
NO FLOWERS FOR THE “FLOWER THROWER”

NO FLOWERS FOR THE “FLOWER THROWER”

Anonymous Street-Art artist lost TM protection for one of his most iconic motifs for allegedly having filed the mark in bad faith. Banksy is certainly one of the hottest artists of our time. His Street-Art artworks suddenly appear in the most unusual places. The...

mehr lesen
ADLON STAYS EXCLUSIVELY WITH KEMPINSKY

ADLON STAYS EXCLUSIVELY WITH KEMPINSKY

The brand „Adlon“ remains exclusively reserved for the Berlin luxury hotel Adlon Kempinski. The first instance court of the European Union (EuG) in Luxembourg dismissed a complaint of the sanitary products manufacturer Kludi on Wednesday, which wanted to sell bathroom...

mehr lesen
PATENT TROLLS SUCCESSFUL AGAINST APPLE

PATENT TROLLS SUCCESSFUL AGAINST APPLE

According to a recent decision of a US court in Texas, technology giant Apple has infringed five patents hold by Optis Wireless Technology and was sentenced in the first instance to pay damages of at least half a billion dollar. Apple has announced taking the decision...

mehr lesen
DOES REMDESIVIR KNOCK OUT CORONA?

DOES REMDESIVIR KNOCK OUT CORONA?

Currently, there are intensive reports on the active Remdesivir from the US pharmaceutical giant Gilead. Chemically, the substance is a 1′-cyano 4-aza-7,9-didesazaadenosine C analogue of adenosine: It is a monophosphoramidate prodrug that is converted by metabolism...

mehr lesen
GERMAN UTILITY MODELS – SMART IP WEAPONS

GERMAN UTILITY MODELS – SMART IP WEAPONS

Enforceable intellectual property rights in Europe are of great strategic and economic importance. Many companies, especially from the Far East, are therefore interested in getting their international applications granted quickly in at least one European heartland....

mehr lesen
Halloumi cheese

Halloumi cheese

Halloumi is a cheese made from sheep’s and goat’s milk, traditionally produced in the Eastern Mediterranean. It is particularly typical for the Cypriot cuisine. It is also very popular in Germany, especially among BBQ lovers, because it keeps its shape during grilling...

mehr lesen
THE IMPACT OF BREXIT ON UNION TRADEMARKS

THE IMPACT OF BREXIT ON UNION TRADEMARKS

On 1 February 2020, the United Kingdom left the European Union. BREXIT will also change the IP landscape in Europe. While the field of patents will hardly be affected, as membership in the EPC is not linked to membership in the EU (and the time lag to the European...

mehr lesen
FRIDAYS FOR … TRADEMARKS

FRIDAYS FOR … TRADEMARKS

On the day before Christmas last year, an application was filed for the Union trade mark 018171380 for classes 35, 36, 41 and 42. The services covered range from marketing and sales promotion, financial and cultural activities to the provision of scientific...

mehr lesen

Our Authors

Bernd Fabry is founder and CEO of IP2. He is a qualified German and European Patent and Trademark Attorney. He has more than 25 years company experience as Head of IP departments. 

Dr. Bernd Fabry - CEO

We are pleased that our Scientific Adviser, Dr. Martin Fabry from the University of Cambridge, will now report regularly on new developments in this exciting field.

Dr. Martin Fabry - Scientific Advisor